Literature DB >> 27844292

On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites.

Kai Yuan1,2, Ying Han3, Kenji Hashimoto4, Lin Lu5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27844292      PMCID： PMC5567489          DOI： 10.1007/s12264-016-0082-1

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  26 in total

Review 1.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Authors:  Ronald S Duman; Bhavya Voleti
Journal:  Trends Neurosci       Date:  2012-01       Impact factor: 13.837

Review 2.  Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.

Authors:  Chadi G Abdallah; Gerard Sanacora; Ronald S Duman; John H Krystal
Journal:  Annu Rev Med       Date:  2014-10-17       Impact factor: 13.739

3.  Stereoselective and regiospecific hydroxylation of ketamine and norketamine.

Authors:  Zeruesenay Desta; Ruin Moaddel; Evan T Ogburn; Cong Xu; Anuradha Ramamoorthy; Swarajya Lakshmi Vattem Venkata; Mitesh Sanghvi; Michael E Goldberg; Marc C Torjman; Irving W Wainer
Journal:  Xenobiotica       Date:  2012-05-21       Impact factor: 1.908

4.  Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.

Authors:  Hiroyuki Koike; Shigeyuki Chaki
Journal:  Behav Brain Res       Date:  2014-06-05       Impact factor: 3.332

5.  Taming the ketamine tiger. 1965.

Authors:  Edward F Domino
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

6.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

7.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

8.  Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.

Authors:  Rebecca B Price; Dan V Iosifescu; James W Murrough; Lee C Chang; Rayan K Al Jurdi; Syed Z Iqbal; Laili Soleimani; Dennis S Charney; Alexandra L Foulkes; Sanjay J Mathew
Journal:  Depress Anxiety       Date:  2014-03-25       Impact factor: 6.505

9.  Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.

Authors:  Ruin Moaddel; Galia Abdrakhmanova; Joanna Kozak; Krzysztof Jozwiak; Lawrence Toll; Lucita Jimenez; Avraham Rosenberg; Thao Tran; Yingxian Xiao; Carlos A Zarate; Irving W Wainer
Journal:  Eur J Pharmacol       Date:  2012-11-23       Impact factor: 4.432

10.  BDNF release is required for the behavioral actions of ketamine.

Authors:  Ashley E Lepack; Manabu Fuchikami; Jason M Dwyer; Mounira Banasr; Ronald S Duman
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176
View more
  2 in total

1.  Special Topic on Mental Health and Addiction.

Authors:  Lin Lu; Wenhua Zhou
Journal:  Neurosci Bull       Date:  2016-11-21       Impact factor: 5.203

Review 2.  Drug addiction: a curable mental disorder?

Authors:  Jian-Feng Liu; Jun-Xu Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.